[ Price : $8.95]
FDA recommends that ERC-USA and the University of California, Irvine, pursue a confirmatory Phase 3 registration trial for ERC 167...[ Price : $8.95]
FDA approves Bausch + Lombs ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.[ Price : $8.95]
FDA approves a new dosage regimen 120-minute intravenous infusion every two weeks for Imclones Erbitux (cetuximab) for treating ...[ Price : $8.95]
Qmart recalls all lots of its Imperial Gold 2000, PremierZen Extreme 3000, Burro en Primavera 60000 and Imperial Platinum 2000 aft...[ Price : $8.95]
In preparation for a 7/15 FDA advisory committee meeting to consider a FibroGen NDA for roxadustat, the company clarifies some of ...[ Price : $8.95]
CBER cautions Curex, Inc., New York, NY, that it is unlawfully marketing and distributing allergy drops and drop compounds.[ Price : $8.95]
FDA warns RPK Pharmaceuticals about a listing discrepancy for a drug cream it manufactures.[ Price : $8.95]
The 9th Circuit Court of Appeals reverses part of a California federal court decision that dismissed all whistleblower claims agai...